Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020068986 - FORMULATIONS FOR TREATMENT OF DRY EYE DISEASE

Publication Number WO/2020/068986
Publication Date 02.04.2020
International Application No. PCT/US2019/052961
International Filing Date 25.09.2019
IPC
B27N 3/06 2006.01
BPERFORMING OPERATIONS; TRANSPORTING
27WORKING OR PRESERVING WOOD OR SIMILAR MATERIAL; NAILING OR STAPLING MACHINES IN GENERAL
NMANUFACTURE BY DRY PROCESSES OF ARTICLES, WITH OR WITHOUT ORGANIC BINDING AGENTS, MADE FROM PARTICLES OR FIBRES CONSISTING OF WOOD OR OTHER LIGNOCELLULOSIC OR LIKE ORGANIC MATERIAL
3Manufacture of substantially flat articles, e.g. boards, from particles or fibres
06Making particle boards or fibreboards, with preformed covering layers, the particles or fibres being compressed with the layers to a board in one single pressing operation
B27N 7/00 2006.01
BPERFORMING OPERATIONS; TRANSPORTING
27WORKING OR PRESERVING WOOD OR SIMILAR MATERIAL; NAILING OR STAPLING MACHINES IN GENERAL
NMANUFACTURE BY DRY PROCESSES OF ARTICLES, WITH OR WITHOUT ORGANIC BINDING AGENTS, MADE FROM PARTICLES OR FIBRES CONSISTING OF WOOD OR OTHER LIGNOCELLULOSIC OR LIKE ORGANIC MATERIAL
7After-treatment, e.g. reducing swelling or shrinkage, surfacing; Protecting the edges of boards against access of humidity
CPC
A61K 31/47
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
A61K 47/40
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
40Cyclodextrins; Derivatives thereof
A61K 9/0048
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0048Eye, e.g. artificial tears
A61K 9/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
A61P 27/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
04Artificial tears; Irrigation solutions
Applicants
  • ALDEYRA THERAPEUTICS, INC. [US]/[US]
Inventors
  • CLARK, David
  • BRADY, Todd
  • MACDONALD, Susan
  • MACHATHA, Stephen Gitu
Agents
  • REID, Andrea L.C.
  • ARICO, Joseph W.
  • FLEMING, Paul R.
  • OH, Euk Charlie
  • SCALTRITO, Donald V.
  • PAGLIA, Danielle M.
  • WANG, Gang
  • PRAIRIE, Nicholas
  • DAVIS, Chad E.
  • STEVENSON, Christian
Priority Data
62/736,41725.09.2018US
62/824,23326.03.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) FORMULATIONS FOR TREATMENT OF DRY EYE DISEASE
(FR) FORMULATIONS POUR LE TRAITEMENT DE LA MALADIE DE L'ŒIL SEC
Abstract
(EN)
The present invention provides a reproxalap ophthalmic solution, and methods of using the same for treating dry eye disease.
(FR)
La présente invention concerne une solution ophtalmique à base de reproxalap, et des procédés d'utilisation de celle-ci pour traiter la maladie de l'œil sec.
Latest bibliographic data on file with the International Bureau